l1210 murine leukemia and 8226 human myeloma cells were treated with alpha-difluoromethylornithine ( dfmo ) to reduce intracellular polyamine levels via inhibition of ornithine decarboxylase .
C0002260
alpha-difluoromethylornithine
C0029282
ornithine decarboxylase